CERS News and Press, Cerus Corporation From 04/02/20

Cerus Corporation (Nasdaq: CERS) announced today that the International Society of Blood Transfusion (ISBT) Working Party on Global Blood Safety issued a new document titled “ Points to consider in the preparation and transfusion of COVID-19 convalescent plasma .” The document w...

Cerus Corporation (Nasdaq: CERS) announced today that the University Hospital Basel transfused the first two COVID-19 patients with INTERCEPT treated coronavirus convalescent plasma (CCP). Cerus’ field team supported the INTERCEPT system implementation which was completed in one week. ...

Gainers: IFRX   +40.1% .   CERS   +9.9% . NVAX   +8.3% . TWOU   +4.7% . More news on: InflaRx N.V., Cerus Corporation, Novavax, Inc., Stocks on the move, , Read more ...

Cerus (NASDAQ: CERS ) has formed a collaborative research group with the aim of optimizing convalescent plasma therapy for COVID-19 patients. More news on: Cerus Corporation, Healthcare stocks news, Stocks on the move, Read more ...

Cerus Corporation (Nasdaq: CERS) announced today that it has formed a collaborative research group with the aim of optimizing convalescent plasma therapy for COVID-19 patients. The research group seeks to define the key characteristics that influence the efficacy of convalescent plasma, inclu...

Allied Healthcare Products (NASDAQ: AHPI ) +71% . More news on: Allied Healthcare Products, Inc., GAIN Capital Holdings, Inc., Co-Diagnostics, Inc., Stocks on the move, , Read more ...

Cerus Corp. ( CERS ) recently reported their Q4 earnings with a slight miss on EPS and a slight beat on revenue. Cerus finished 2019 with record revenue of $20.9M in Q4 and an annual total of $74.6M; which was at the uppermost end of the company's guidance of $72M-$75M. What is more, the...

Image source: The Motley Fool. Cerus Corporation   (NASDAQ: CERS) Q4 2019 Earnings Call Feb 20, 2020 , 4:30 p.m. ET Operator Continue reading

Cerus Corporation (CERS) Q4 2019 Earnings Conference Call February 20, 2020 04:30 PM ET Company Participants Tim Lee - Investor Relations Obi Greenman - President and Chief Executive Officer Kevin Green - Chief Financial Officer Carol Moore - SVP of Regulatory Affairs and Quali...

Cerus Corporation (Nasdaq: CERS) today announced complete financial results for the fourth quarter and year ended December 31, 2019. Recent developments and highlights include: Total fourth quarter revenue of $26.5 million. Record fourth quarter product revenue of $20.9 million,...